The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 17, 2026

Filed:

Nov. 25, 2020
Applicant:

Yuhan Corporation, Seoul, KR;

Inventors:

Seyoung Lim, Seoul, KR;

Young Bong Park, Seoul, KR;

Sukyung Kim, Seoul, KR;

Bo Ra Sim, Seoul, KR;

Wonee Chong, Seoul, KR;

Hyun Ho Choi, Seoul, KR;

Ji Eun Yang, Seoul, KR;

Mi Kyeong Ju, Seoul, KR;

Won Tae Kim, Seoul, KR;

Youn Woo Lee, Seoul, KR;

Junhwan Kim, Seoul, KR;

Assignee:

YUHAN CORPORATION, Seoul, KR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 14/475 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
C07K 14/475 (2013.01); C12N 15/63 (2013.01); C07K 2319/30 (2013.01);
Abstract

A fusion protein including a GDF15 variant having increased physiological activity and in vivo stability, and a pharmaceutical composition containing the same are disclosed. The GDF15 variant or long-acting GDF15 fusion protein is superior to conventional GDF15 variants in terms of in vitro efficacy, binding affinity for GDF15 receptors, and body weight loss effect. Therefore, a pharmaceutical composition containing, as an active ingredient, the GDF15 variant, the long-acting GDF15 fusion protein, or a dimer of the fusion protein, causes appetite suppression, and thus can be effectively used as a therapeutic agent for metabolic diseases or obesity. Furthermore, the pharmaceutical composition can be used in combination therapy or the like with chemical drugs and other therapeutic agents for metabolic diseases, and can be effectively used in combination therapy with conventional therapeutic agents for metabolic diseases or obesity.


Find Patent Forward Citations

Quick Actions:

Lim, Seyoung. (2026). Long-acting gdf15 fusion protein and pharmaceutical composition comprising same (U.S. Patent No. 12799177). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/12799177

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…